3D Bioprinting

3D bioprinting allows researchers to model disease, create custom 3D tissue, and study the body outside the body with a level of control and repeatability that was simply not possible as recently as 5 years ago.

For pharmaceutical development, 3D bioprinting offers a means of testing drugs faster, at a lower cost, and with greater biological relevance than animal testing or 2D in vitro studies.

In the biomedical devices field, 3D bioprinting has enabled new developments such as sugar stents to help surgeons join veins with fewer complications, and systems for improved drug delivery.

Personalized and regenerative medicine continue to grow in popularity, and bioprinting will give doctors and researchers the tools to better target treatments and improve patient outcomes.

There’s a large and growing need for an alternative to organ and tissue donation. 3D bioprinting is an exciting new tool with the potential to eliminate the organ transplant waiting list.